Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New Onset Diabetes After Transplant”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Post-approval studies (Phase 4)Ended earlyNCT03642184
What this trial is testing

Efficacy and Safety of Empagliflozin in NODAT

Who this might be right for
New Onset Diabetes After TransplantKidney Transplant; Complications
RenJi Hospital 6
Testing effectiveness (Phase 2)Study completedNCT03304626
What this trial is testing

Budesonide for Liver Transplant Immune Suppression

Who this might be right for
Acute Cellular Graft RejectionNew Onset Diabetes After Transplant
University of Cincinnati 40
Post-approval studies (Phase 4)UnknownNCT02036554
What this trial is testing

Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

Who this might be right for
Kidney; Complications, Allograft
Seoul St. Mary's Hospital 234
Post-approval studies (Phase 4)Study completedNCT01928199
What this trial is testing

Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant

Who this might be right for
Posttransplant Diabetes Mellitus
Washington University School of Medicine 61
Large-scale testing (Phase 3)Study completedNCT01680185
What this trial is testing

Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation

Who this might be right for
Hyperglycemia
Medical University of Vienna 85
Not applicableLooking for participantsNCT06950788
What this trial is testing

Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant

Who this might be right for
Cirrhosis, LiverDiabetes Mellitus RiskTransplant; Failure, Liver+1 more
University of Chicago 60
Post-approval studies (Phase 4)Study completedNCT01683331
What this trial is testing

A Clinical Trial to Prevent New Onset Diabetes After Transplantation

Who this might be right for
Prevention of New Onset Diabetes Among Kidney Transplant Patients
University of Michigan 251
Not applicableStudy completedNCT00442988
What this trial is testing

Prediction of NODAT After Renal Transplantation

Who this might be right for
Renal Transplantation
KU Leuven 360
Large-scale testing (Phase 3)UnknownNCT02849899
What this trial is testing

Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period

Who this might be right for
Disorder Related to Renal TransplantationDiabetes
Centre Hospitalier Universitaire de Besancon 186
Testing effectiveness (Phase 2)Study completedNCT00980356
What this trial is testing

Vildagliptin in New Onset Diabetes After Transplantation

Who this might be right for
Diabetes Mellitus
Medical University of Vienna 32
Post-approval studies (Phase 4)Study completedNCT01742624
What this trial is testing

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

Who this might be right for
de Novo Kidney Transplantation
Astellas Pharma Korea, Inc. 60
Post-approval studies (Phase 4)Ended earlyNCT01963728
What this trial is testing

Comparison of Insulin Therapy in Treating Post-Transplant Diabetes

Who this might be right for
Diabetes Mellitus
Inova Health Care Services 2
Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3
Post-approval studies (Phase 4)UnknownNCT01875224
What this trial is testing

Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

Who this might be right for
New Onset Diabetes After TransplantKidney Transplantation
University of Arizona 32
Post-approval studies (Phase 4)Study completedNCT00171496
What this trial is testing

Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

Who this might be right for
Kidney Transplant
Novartis 693
Post-approval studies (Phase 4)Study completedNCT02083991
What this trial is testing

Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

Who this might be right for
Diabetes Mellitus
Vastra Gotaland Region 224
Not applicableLooking for participantsNCT07512804
What this trial is testing

Post-Transplant Diabetes Outcomes Prediction

Who this might be right for
New Onset Diabetes After Transplantation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Not applicableUnknownNCT06012799
What this trial is testing

Continuous Glucose Monitoring in Peri-operative Period in Kidney Transplant Recipients

Who this might be right for
New Onset Diabetes After Transplantation
Seoul National University Hospital 100
Post-approval studies (Phase 4)Study completedNCT00171717
What this trial is testing

Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant

Who this might be right for
Maintenance Liver Transplant Patients With New Onset Diabetes
Novartis 39
Not applicableStudy completedNCT04030013
What this trial is testing

"Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)"

Who this might be right for
New Onset Diabetes After TransplantDiabetes Mellitus
Dasman Diabetes Institute 210
Load More Results